Biotech Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds November 3, 2024
Biotech Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 2, 2024
Biotech Kling Biotherapeutics to Present Key Applications for its Primary B-Cell Immortalization, Screening and Antibody Optimization Platform Technologies at PEGS Europe October 31, 2024
Biotech Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 2025 October 28, 2024
Biotech ADVANCED NANOTHERAPIES ANNOUNCES POSITIVE RESULTS IN ITS FIRST-IN-HUMAN TRIAL AND PLANS FOR U.S. EARLY FEASIBILITY STUDY FOR SIRPLUX™ DUO DRUG-COATED BALLOON October 27, 2024
Biotech RiboX Therapeutics Announces FDA Clearance for IND Application of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation October 26, 2024
Biotech Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC) October 25, 2024
Search
Biotech
November 3, 2024
November 2, 2024
November 1, 2024
October 31, 2024
October 30, 2024
October 29, 2024
October 28, 2024
October 27, 2024
October 26, 2024
October 25, 2024
